Home | Welcome to Contract Pharma   
Last Updated Friday, May 24 2013
Print

Promotions & Moves

Related Searches:

Filter by:

January 26, 2009
Michael D. Ironside, Ph.D. has been named director of global project management at AMRI. In this newly created role, Dr. Ironside will be responsible for overseeing all project management activities related to products moving through AMRI’s pha…   Read More »
January 22, 2009
Rick Lapointe has been appointed vice president of technology and acquisitions at OSO BioPharmaceuticals Manufacturing. Mr. Lapointe will be responsible for working with the senior leadership team to increase the company’s capabilities, identif…   Read More »
January 20, 2009
Maria Lusk has been appointed director of client management at Eden Biodesign's U.S. subsidiary. Ms. Lusk's appointment coincides with the expansion of the U.S. office in Research Triangle Park, NC and establishes the company’s U.S. project man…   Read More »
January 16, 2009
Gary W. Thompson has joined bioRASI as vice president of business development. The company has expanded its worldwide operations and is now upgrading its business development functions. Mr. Thompson will lead these global efforts. "We are ext…   Read More »
January 15, 2009
Josephine Hoppe has been appointed corporate vice president and chief information officer, Parexel International Corp. Ms. Hoppe is responsible for managing the company's IT initiatives and integrating technology solutions with business processes on…   Read More »
January 13, 2009
Junan Guo, Ph.D. has been appointed senior director, analytical and quality services, AMRI. Dr. Guo replaces Dr. Steven Hagen, who was promoted to vice president of pharmaceutical development and manufacturing in September 2008. Dr. Guo will overs…   Read More »
January 12, 2009
Albert Ros has been appointed executive vice president of sales and marketing for Boehringer Ingelheim's prescription medicines business. In his new role, Mr. Ros will lead the U.S. sales and marketing strategy of the company's core brands. "…   Read More »
January 7, 2009
Rudy Howard has been named senior vice president and chief financial officer, MDSPS. Mr. Howard has experience as a senior financial executive in the pharmaceutical and CRO industry sectors, including six years as chief financial officer at Pharmaceu…   Read More »
January 6, 2009
Thomas M. Salus has been appointed vice president, contract services, Avéma Pharma Solutions, a division of PL Developments, and Richard Thome has been named senior vice president, operations of both PL Developments and Avéma Pharma Sol…   Read More »
January 6, 2009
Rajiv De Silva has been appointed chief operating officer of Specialty Pharmaceuticals, Valeant Pharmaceuticals International, effective January 5, 2009. Mr. De Silva will be responsible for overseeing the U.S., Canadian and Australian specialty phar…   Read More »
January 5, 2009
Fred Kurland has been appointed vice president, finance and chief financial officer at Xoma, Ltd. Mr. Kurland will be responsible for directing the company's financial strategy, accounting, financial planning and investor relations functions.  …   Read More »
December 30, 2008
Roger Viney, Ph.D. has been named director of sales & marketing Europe and Asia for Hovione. Thomas Eisele, Ph.D. has been named general manager R&D at the company and Steve Beagle has been named director of sales & marketing, North Ameri…   Read More »
December 30, 2008
Matthew K. Fust has been named executive vice president and chief financial officer of Onyx Pharmaceuticals. Mr. Fust will serve as Onyx's principal financial and accounting officer and report to N. Anthony Coles, M.D., the company's president and ch…   Read More »
December 23, 2008
Kerri Schoedel, Ph.D. has been promoted to scientific director, clinical pharmacology for Kendle's Early Stage unit in Toronto. Dr. Schoedel will provide overall scientific direction and leadership to the clinical pharmacology group, as well as lead…   Read More »
December 11, 2008
Joern Aldag will resign from his position as president & chief executive officer of Evotec, effective December 31, 2008. Dr. Mario Polywka, chief operating officer, and Dr. Klaus Maleck, chief financial officer, will jointly lead the Company unti…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On